These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3965152)

  • 1. Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans.
    Ohnuma T; Norton L; Andrejczuk A; Holland JF
    Cancer Res; 1985 Jan; 45(1):464-9. PubMed ID: 3965152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of vindesine infusion.
    Rahmani R; Kleisbauer JP; Cano JP; Martin M; Barbet J
    Cancer Treat Rep; 1985; 69(7-8):839-44. PubMed ID: 2410121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of recombinant interleukin 2 in humans.
    Konrad MW; Hemstreet G; Hersh EM; Mansell PW; Mertelsmann R; Kolitz JE; Bradley EC
    Cancer Res; 1990 Apr; 50(7):2009-17. PubMed ID: 2317789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
    Ohnuma T; Greenspan EM; Holland JF
    Cancer Treat Rep; 1980 Jan; 64(1):25-30. PubMed ID: 6929728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of vindesine and vincristine in humans.
    Owellen RJ; Root MA; Hains FO
    Cancer Res; 1977 Aug; 37(8 Pt 1):2603-7. PubMed ID: 872088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of vindesine bolus and infusion.
    Jackson DV; Sethi VS; Long TR; Muss HB; Spurr CL
    Cancer Chemother Pharmacol; 1984; 13(2):114-9. PubMed ID: 6467494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of vindesine.
    Nelson RL; Dyke RW; Root MA
    Cancer Chemother Pharmacol; 1979; 2(4):243-46. PubMed ID: 455583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of vinblastine by continuous intravenous infusion.
    Lu K; Yap HY; Loo TL
    Cancer Res; 1983 Mar; 43(3):1405-8. PubMed ID: 6825110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer.
    Nelson RL
    Med Pediatr Oncol; 1982; 10(2):115-27. PubMed ID: 7070351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of vindesine administration by bolus injection and by 24-hour infusion.
    Gilby ED
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():47-51. PubMed ID: 7438121
    [No Abstract]   [Full Text] [Related]  

  • 11. Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).
    Rahmani R; Martin M; Barbet J; Cano JP
    Cancer Res; 1984 Dec; 44(12 Pt 1):5609-13. PubMed ID: 6498821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 125I-radiolabelled probe for vinblastine and vindesine radioimmunoassays: applications to measurements of vindesine plasma levels in man after intravenous injections and long-term infusions.
    Rahmani R; Barbet J; Cano JP
    Clin Chim Acta; 1983 Mar; 129(1):57-69. PubMed ID: 6851151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity and pharmacology of bolus vindesine injection and prolonged vindesine infusion.
    Hande K; Gay J; Gober J; Greco FA
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():25-30. PubMed ID: 7438118
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of partially pure gamma-interferon in cancer patients.
    Gutterman JU; Rosenblum MG; Rios A; Fritsche HA; Quesada JR
    Cancer Res; 1984 Sep; 44(9):4164-71. PubMed ID: 6430557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of vincristine sulfate in adult cancer patients.
    Sethi VS; Jackson DV; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Spurr CL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3551-5. PubMed ID: 7260915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A; van Groeningen CJ; Kraal I; Gall H; Peters GJ; Lankelma J; Pinedo HM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of vindesine: repeated treatments by intravenous bolus injections.
    Rahmani R; Martin M; Favre R; Cano JP; Barbet J
    Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1409-17. PubMed ID: 6542010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.